4-methyl-2-[(2R)-piperidin-2-yl]-6-(2-propylpyrazol-3-yl)pyrimidine

C16H23N5 — CID 124964353

IUPAC4-methyl-2-[(2R)-piperidin-2-yl]-6-(2-propylpyrazol-3-yl)pyrimidine
SMILESCCCn1nccc1-c1cc(C)nc([C@H]2CCCCN2)n1
InChIInChI=1S/C16H23N5/c1-3-10-21-15(7-9-18-21)14-11-12(2)19-16(20-14)13-6-4-5-8-17-13/h7,9,11,13,17H,3-6,8,10H2,1-2H3/t13-/m1/s1
InChIKeyHWXMXUDGUVNCJE-CYBMUJFWSA-N
MW285.39 g/mol
LogP2.87
Rot. Bonds4

About 4-methyl-2-[(2R)-piperidin-2-yl]-6-(2-propylpyrazol-3-yl)pyrimidine

4-methyl-2-[(2R)-piperidin-2-yl]-6-(2-propylpyrazol-3-yl)pyrimidine (PubChem CID 124964353) has the molecular formula C16H23N5 and a molecular weight of 285.39 g/mol. Its IUPAC name is 4-methyl-2-[(2R)-piperidin-2-yl]-6-(2-propylpyrazol-3-yl)pyrimidine.

Molecular Properties

Compound Name4-methyl-2-[(2R)-piperidin-2-yl]-6-(2-propylpyrazol-3-yl)pyrimidine
PubChem CID124964353
Molecular FormulaC16H23N5
Molecular Weight285.39 g/mol
Exact Mass285.20
IUPAC Name4-methyl-2-[(2R)-piperidin-2-yl]-6-(2-propylpyrazol-3-yl)pyrimidine
SMILESCCCn1nccc1-c1cc(C)nc([C@H]2CCCCN2)n1
InChIInChI=1S/C16H23N5/c1-3-10-21-15(7-9-18-21)14-11-12(2)19-16(20-14)13-6-4-5-8-17-13/h7,9,11,13,17H,3-6,8,10H2,1-2H3/t13-/m1/s1
InChIKeyHWXMXUDGUVNCJE-CYBMUJFWSA-N
XLogP2.87
TPSA55.63 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms21
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500285.39
LogP ≤ 52.87
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze 4-methyl-2-[(2R)-piperidin-2-yl]-6-(2-propylpyrazol-3-yl)pyrimidine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-methyl-6-(2-methylpyrazol-3-yl)-2-[(2R)-pyrrolidin-2-yl]pyrimidine
CID 124641631
4-methyl-2-[(3R)-piperidin-3-yl]-6-(2-propylpyrazol-3-yl)pyrimidine
CID 124971396
N,N-dimethyl-2-[4-methyl-6-(2-propylpyrazol-3-yl)pyrimidin-2-yl]pyrrolidine-1-sulfonamide
CID 127245981
4-cyclohexyl-6-methyl-2-pyrrolidin-2-ylpyrimidine
CID 63319069
4-methyl-6-(2-methylpropyl)-2-piperidin-2-ylpyrimidine
CID 116893407
4-methyl-6-(2-methylphenyl)-2-pyrrolidin-2-ylpyrimidine
CID 116893348
4-(2-ethylpyrazol-3-yl)-6-methyl-2-[(2S)-1-methylsulfonylpiperidin-2-yl]pyrimidine
CID 125002851
4-(2-ethylpyrazol-3-yl)-6-methyl-2-[(2R)-1-methylsulfonylpiperidin-2-yl]pyrimidine
CID 125002852
4-(2-ethylpyrazol-3-yl)-6-methyl-2-(1-propan-2-ylpiperidin-3-yl)pyrimidine
CID 110101210
4-(2-ethylpyrazol-3-yl)-6-methyl-2-(1-methylsulfonylpyrrolidin-2-yl)pyrimidine
CID 110101083
(2S)-2-[4-(2-ethylpyrazol-3-yl)-6-methylpyrimidin-2-yl]-N,N-dimethylpiperidine-1-sulfonamide
CID 124948122
4-methyl-6-phenoxy-2-[(2S)-piperidin-2-yl]pyrimidine
CID 124938852

Frequently Asked Questions

What is the IUPAC name of 4-methyl-2-[(2R)-piperidin-2-yl]-6-(2-propylpyrazol-3-yl)pyrimidine?
The IUPAC name of 4-methyl-2-[(2R)-piperidin-2-yl]-6-(2-propylpyrazol-3-yl)pyrimidine (CID 124964353) is 4-methyl-2-[(2R)-piperidin-2-yl]-6-(2-propylpyrazol-3-yl)pyrimidine.
What is the SMILES notation for 4-methyl-2-[(2R)-piperidin-2-yl]-6-(2-propylpyrazol-3-yl)pyrimidine?
The canonical SMILES for 4-methyl-2-[(2R)-piperidin-2-yl]-6-(2-propylpyrazol-3-yl)pyrimidine is CCCn1nccc1-c1cc(C)nc([C@H]2CCCCN2)n1.
What is the InChIKey of 4-methyl-2-[(2R)-piperidin-2-yl]-6-(2-propylpyrazol-3-yl)pyrimidine?
The InChIKey is HWXMXUDGUVNCJE-CYBMUJFWSA-N. The full InChI is InChI=1S/C16H23N5/c1-3-10-21-15(7-9-18-21)14-11-12(2)19-16(20-14)13-6-4-5-8-17-13/h7,9,11,13,17H,3-6,8,10H2,1-2H3/t13-/m1/s1.
What are the key properties of 4-methyl-2-[(2R)-piperidin-2-yl]-6-(2-propylpyrazol-3-yl)pyrimidine?
4-methyl-2-[(2R)-piperidin-2-yl]-6-(2-propylpyrazol-3-yl)pyrimidine has a molecular weight of 285.39 g/mol, XLogP of 2.87, 4 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 4-methyl-2-[(2R)-piperidin-2-yl]-6-(2-propylpyrazol-3-yl)pyrimidine is sourced from PubChem (CID 124964353), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).